The DCGI (Drugs Controller General of India) on Wednesday issued an alert regarding a stolen batch of Sanofi India's insulin formulation, Lantus SoloStar (Insulin Glargine Injection IP, r-DNA origin, 100 IU/mL), with batch number 5F0347B.
BJP leader K. Annamalai has criticised the Tamil Nadu government for its handling of a case involving a private pharmaceutical company in Kanchipuram, allegedly linked to the deaths of 23 people in Madhya Pradesh and three children in Rajasthan due to a faulty drug.
In a letter dated October 7, the Drugs Controller General of India (DCGI) Dr Rajeev Singh Raghuvanshi emphasised the "critical importance of testing new materials, including the excipients, before their use in the manufacturing of pharmaceutical formulations."
The Drugs Controller General of India (DCGI) has reduced the time required for blood bank licensing from a year to a maximum of four months by transitioning the entire process to a digital platform.
Drugs Controller General of India (DCGI) Dr Rajeev Raghuvanshi, has said that 11 countries in the world have recognised Indian pharmacopoeia as their standard.
As per senior official sources, the DCGI is actively taking action against manufacturing companies producing drugs that do not meet the required standards of quality (NSQ). This proactive approach aims to protect public health and maintain trust in the healthcare system.
The Drugs Controller General of India (DCGI) on Wednesday suspended the product PresVu produced by Entod Pharmaceuticals after the company failed to respond to the queries on the product for which the DGCI says no approval was granted.
Union Health Minister JP Nadda on Wednesday said that India needs to have a world-class regulatory framework to match the country's global reputation as 'Pharmacy of the World'.
The National Human Rights Commission (NHRC) sent notices to the Delhi Chief Secretary, Drugs Controller General of India, and Police Commissioner on Friday after the epilepsy drug 'Sodium Valproate' failed a quality test.
Union Health Minister Mansukh Mandaviya has directed the Drugs Controller General of India (DCGI) to take stringent actions against those pharmaceutical manufacturing companies that make spurious drugs.
The Government of India has cancelled the licenses of 18 pharma companies for manufacturing spurious medicines following an inspection by the Drugs Controller General of India (DCGI) on 76 companies across 20 states, sources said on Thursday.